Cargando…

A Randomized Study Comparing the Efficacy of Three Hepatitis B Vaccine Induction Regimens in Adult Patients with Hematological Malignancies

OBJECTIVE: Non-responsiveness to hepatitis B virus (HBV) vaccines is not rare in hemato-oncological patients due to disease-associated or treatment-induced immune suppression. Although different strategies have been employed to improve the response rates, to date there is not an approved schedule fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Özkurt, Zübeyde Nur, Suyanı, Elif, Haznedar, Rauf, Yağcı, Münci
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111469/ https://www.ncbi.nlm.nih.gov/pubmed/27094506 http://dx.doi.org/10.4274/tjh.2015.0079

Ejemplares similares

The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies
por: Yağcı, Münci, et al.
Publicado: (2015)

Prevalence of Monoclonal B Lymphocytosis in First-Degree Relatives of Chronic Lymphocytic Leukemia Patients in Turkey
por: Demirci, Taner, et al.
Publicado: (2015)

Risk factors for ICU mortality in patients with hematological malignancies: a single-center, retrospective cohort study from Turkey
por: AYGENCEL, Gülbin, et al.
Publicado: (2022)

Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
por: AYGENCEL, Gülbin, et al.
Publicado: (2021)

Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy
por: Yegin, Zeynep Arzu, et al.
Publicado: (2020)

The Impact of Pre-transplant Cell-free DNA Levels on Leukemia Relapse and Transplant-related Complications in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Yegin, Zeynep Arzu, et al.
Publicado: (2020)

Is It Possible to Predict Pulmonary Complications and Mortality in Hematopoietic Stem Cell Transplantation Recipients from Pre-Transplantation Exhaled Nitric Oxide Levels?
por: Köktürk, Nurdan, et al.
Publicado: (2016)

The Effect of Granulocyte Colony-Stimulating Factor (G-CSF) on Early Complications and Graft-Versus-Host Disease (GVHD) in Allogeneic Stem Cell Transplantation (ASCT) Recipients
por: Aydın Kaynar, Lale, et al.
Publicado: (2023)

PB2702: POLYPHARMACY IN HEMATOLOGY PRACTISE: A SINGLE CENTER EXPERIENCE
por: Karişmaz, Kadir, et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
por: Civriz Bozdağ, Sinem, et al.
Publicado: (2022)

Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases
por: Eren, Rafet, et al.
Publicado: (2018)

Drug Resistance in Hematologic Malignancies: Induction Mechanisms, Genetics, and Therapeutics
por: Zhan, Fenghuang, et al.
Publicado: (2015)

Hematologic malignancies of the breast: report of three cases
por: Sosa, Yocelin Joya, et al.
Publicado: (2022)

Cord-Blood Engraftment Using an Enhanced Dual-Conditioning Regimen for Malignant Hematologic Diseases
por: Ding, Jiahua, et al.
Publicado: (2022)

Differentiation of Benign and Malignant Thyroid Nodules with ANFIS by Using Genetic Algorithm and Proposing a Novel CAD-Based Risk Stratification System of Thyroid Nodules
por: Ozturk, Ahmet Cankat, et al.
Publicado: (2023)

Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety
por: La Torre, Giuseppe, et al.
Publicado: (2016)

Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting
por: Hou, Jing-Zhou, et al.
Publicado: (2021)

Factors Associated with Cytomegalovirus Reactivation Following Allogeneic Hematopoietic Stem Cell Transplantation: Human Leukocyte Antigens Might Be Among the Risk Factors
por: Acar1, Kadir, et al.
Publicado: (2014)

Retrospective Evaluation of Effects of Preoperative Anaemia Treatment in Gynaecological and Obstetric Surgical Patients
por: Günaydın, Berrin, et al.
Publicado: (2021)

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
por: Tavitian, Suzanne, et al.
Publicado: (2015)

Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies
por: Klausen, Uffe, et al.
Publicado: (2018)

Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials
por: Luo, Chengxin, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Efficacy in Patients with Hematologic Malignancies: Practical Points for Further Research
por: Guven, Deniz C, et al.
Publicado: (2022)

Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario
por: Krekeler, Carolin, et al.
Publicado: (2022)

Efficacy and Toxicity of Three Induction Chemotherapy Regimens in Locoregionally Advanced Nasopharyngeal Carcinoma: Outcomes of 10-Year Follow-Up
por: Peng, Hao, et al.
Publicado: (2021)

Immunogenicity of the COVID-19 Two-Vaccination Series Among Hematologic Malignancies: Report of Three Cases of Breakthrough Infection
por: Pasikhova, Yanina, et al.
Publicado: (2022)

Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection
por: Kedia, Shiksha, et al.
Publicado: (2014)

Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
por: Chen, Chien-Yuan, et al.
Publicado: (2018)

Adverse Hematological Effects of COVID-19 Vaccination and Pathomechanisms of Low Acquired Immunity in Patients with Hematological Malignancies
por: Yazdani, Armand N., et al.
Publicado: (2023)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

Autophagy in Hematological Malignancies
por: García Ruiz, Olga, et al.
Publicado: (2022)

A Handbook of Essential Drugs and Regimens in Hematological Oncology
por: Rohatiner, A.
Publicado: (1993)

CKD-581 Downregulates Wnt/β-Catenin Pathway by DACT3 Induction in Hematologic Malignancy
por: Kim, Soo Jin, et al.
Publicado: (2022)

A Systemic Lupus Erythematosus Patient with Isolated Neutropenia and Diminished Expression of CD55 and CD59 Similar to Paroxysmal Nocturnal Hemoglobinuria
por: Yıldız, Abdülkerim, et al.
Publicado: (2014)

Clinical Strategies for Enhancing the Efficacy of CAR T-Cell Therapy for Hematological Malignancies
por: Liu, Qianzhen, et al.
Publicado: (2022)

Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma
por: Akhtar, Saad, et al.
Publicado: (2021)

Tumorablative conditioning regimen for haploidentical stem cell transplantation in 102 children with hematologic malignancies: a single-center experience
por: Rongmu, Luo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gplt3nken4rrmdfqtf91ru8oui